Abstract
This paper analyses the emergence and development of a European pharmaceutical system. In particular it reviews and assesses the influence of new institutional and regulatory frameworks on the creation of this pan-European pharmaceutical system. The paper then explores the implications of the formation of this process on our conceptualisation of the more specific 'systems of innovation' approach.
| Original language | English |
|---|---|
| Pages (from-to) | 96-114 |
| Number of pages | 19 |
| Journal | International Journal of Biotechnology |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2002 |
Keywords
- Institutions
- Pharmaceuticals
- Regulation
- Systems of innovation
- Technological innovation
